Showing results (411-420 of 594) with videos related to
Sort By:
Pageof 60
Journal of the Neurological Sciences|September 17, 2019
Cerebral amyloid angiopathy-related transient focal neurological episodes: A transient ischemic attack mimic with an increased risk of intracranial hemorrhageMarta Vales-Montero, Andrés García-Pastor, Ana María Iglesias-Mohedano, et al.Epilepsia|July 21, 2021
Long-term safety and efficacy of add-on cannabidiol in patients with Lennox-Gastaut syndrome: Results of a long-term open-label extension trialAnup D Patel, Maria Mazurkiewicz-Bełdzińska, Richard F Chin, et al.Annals of Surgical Oncology|March 11, 2020
Prognostic Value and Therapeutic Implication of Laparoscopic Extraperitoneal Paraaortic Staging in Locally Advanced Cervical Cancer: A Spanish Multicenter StudyBerta Díaz-Feijoo, Aureli Torné, Álvaro Tejerizo, et al.International Journal of Molecular Sciences|August 22, 2018
Patient-Derived Xenograft Models for Endometrial Cancer ResearchCristian P Moiola, Carlos Lopez-Gil, Silvia Cabrera, et al.Epilepsy & Behavior : E&B|June 17, 2020
Emergency implementation of telemedicine for epilepsy in Spain: Results of a survey during SARS-CoV-2 pandemicEstefanía Conde-Blanco, María Centeno, Ester Tio, et al.Developmental Medicine and Child Neurology|January 26, 2022
Pyridoxine or pyridoxal-5-phosphate treatment for seizures in glycosylphosphatidylinositol deficiency: A cohort studyAllan Bayat, Angel Aledo-Serrano, Antonio Gil-Nagel, et al.Frontiers in Oncology|December 24, 2019
FXYD5/Dysadherin, a Biomarker of Endometrial Cancer Myometrial Invasion and Aggressiveness: Its Relationship With TGF-β1 and NF-κB PathwaysMaría José Besso, Marina Rosso, Lara Lapyckyj, et al.Revista De Neurologia|July 10, 2014
[Bilateral carotid artery occlusion: prognosis and neurosonological features]Javier R Pérez-Sánchez, Andrés García-Pastor, Fernando Díaz-Otero, et al.Frontiers in Oncology|February 7, 2024
Corrigendum: FXYD5/Dysadherin, a biomarker of endometrial cancer myometrial invasion and aggressiveness: its relationship with TGF-β1 and NF-κB pathwaysMaría José Besso, Marina Rosso, Lara Lapyckyj, et al.Molecular Cancer Therapeutics|May 27, 2011
High-risk endometrial carcinoma profiling identifies TGF-β1 as a key factor in the initiation of tumor invasionLaura Muinelo-Romay, Eva Colas, Jorge Barbazan, et al.Pageof 60